Daunorubicin

Generic name: Pronounced as (daw'' noe roo' bi sin)
Brand names
  • Cerubidine®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 12/15/2011

Daunorubicin injection must be given in a hospital or medical facility under the supervision of a doctor who is experienced in giving chemotherapy medications for cancer.

Daunorubicin may cause serious or life-threatening heart problems at any time during your treatment or months to years after your treatment has ended. Your doctor will order tests before and during your treatment to see if your heart is working well enough for you to safely receive daunorubicin. These tests may include an electrocardiogram (ECG; test that records the electrical activity of the heart) and an echocardiogram (test that uses sound waves to measure your heart's ability to pump blood). Your doctor may tell you that you should not receive this medication if the tests show your heart's ability to pump blood has decreased. Tell your doctor if you have or have ever had any type of heart disease or radiation (x-ray) therapy to the chest area. Tell your doctor and pharmacist if you are taking or have ever received certain cancer chemotherapy medications such as doxorubicin (Doxil), epirubicin (Ellence), idarubicin (Idamycin), or mitoxantrone (Novantrone), cyclophosphamide (Cytoxan), or trastuzumab (Herceptin). If you experience any of the following symptoms, call your doctor immediately: shortness of breath; difficulty breathing; swelling of the hands, feet, ankles or lower legs; or fast, irregular, or pounding heartbeat.

Daunorubicin can cause a severe decrease in the number of blood cells in your bone marrow. This may cause certain symptoms and may increase the risk that you will develop a serious infection or bleeding. If you experience any of the following symptoms, call your doctor immediately: fever, sore throat, ongoing cough and congestion, or other signs of infection; unusual bleeding or bruising.

Tell your doctor if you have or have ever had kidney or liver disease. Your doctor may need to adjust your dose if you have kidney or liver disease.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain tests to check your body's response to daunorubicin.

Daunorubicin is used with other chemotherapy drugs to treat a certain type of acute myeloid leukemia (AML; a type of cancer of the white blood cells). Daunorubicin is also used with other chemotherapy drugs to treat a certain type of acute lymphocytic leukemia (ALL; a type of cancer of the white blood cells). Daunorubicin is in a class of medications called anthracyclines. It works by slowing or stopping the growth of cancer cells in your body.

Daunorubicin comes as a solution (liquid) or as a powder to be mixed with liquid to be injected intravenously (into a vein) by a doctor or nurse in a medical facility along with other chemotherapy medications. When daunorubicin is used to treat AML, it is usually injected once a day on certain days of your treatment period. When daunorubicin is used to treat ALL, it is usually injected once a week. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have.

Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before receiving daunorubicin injection,

  • tell your doctor and pharmacist if you are allergic to daunorubicin, any other medications, or any of the ingredients in daunorubicin injection. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: azathioprine (Imuran), cyclosporine (Neoral, Sandimmune), methotrexate (Rheumatrex, Trexall), sirolimus (Rapamune), and tacrolimus (Prograf). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Other medications may also interact with daunorubicin, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • tell your doctor if you have or have ever had any medical condition.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. You should not become pregnant while you are receiving daunorubicin injection. If you become pregnant while receiving daunorubicin, call your doctor. Daunorubicin may harm the fetus.

Unless your doctor tells you otherwise, continue your normal diet.

  • Daunorubicin may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • vomiting

    • sores in the mouth and throat

    • diarrhea

    • stomach pain

    • hair loss

    • red urine

  • Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately:

    • redness, pain, swelling, or burning at the site where the injection was given

    • rash

    • hives

    • itching

    • difficulty breathing or swallowing

  • Daunorubicin may increase the risk that you will develop other cancers. Talk to your doctor about the risks of taking this medication.

  • Daunorubicin may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • Daunomycin
  • Rubidomycin

Drug Interaction
Repaglinide Repaglinide Daunorubicin may decrease the excretion rate of Repaglinide which could result in a higher serum level.
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Daunorubicin is combined with Leflunomide.
Nevirapine Nevirapine The metabolism of Nevirapine can be increased when combined with Daunorubicin.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Daunorubicin.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Daunorubicin.
Anagrelide Anagrelide The risk or severity of bleeding can be increased when Anagrelide is combined with Daunorubicin.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Daunorubicin.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be increased when combined with Daunorubicin.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole Erythromycin may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Fenofibrate Fenofibrate Daunorubicin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Daunorubicin is combined with Mycophenolic acid.
Prednisone Prednisone The risk or severity of adverse effects can be increased when Prednisone is combined with Daunorubicin.
Reserpine Reserpine Reserpine may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Daunorubicin.
Triamcinolone Triamcinolone The risk or severity of adverse effects can be increased when Triamcinolone is combined with Daunorubicin.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Daunorubicin.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Daunorubicin.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be decreased when combined with Daunorubicin.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Methylprednisolone.
Metronidazole Injection Metronidazole Injection The metabolism of Metronidazole can be increased when combined with Daunorubicin.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Zidovudine is combined with Daunorubicin.
Cyclosporine Cyclosporine Daunorubicin may increase the immunosuppressive activities of Cyclosporine.
Ondansetron Ondansetron The metabolism of Ondansetron can be increased when combined with Daunorubicin.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Daunorubicin.
Dofetilide Dofetilide The metabolism of Dofetilide can be decreased when combined with Daunorubicin.
Hydroxychloroquine Hydroxychloroquine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Hydroxychloroquine.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Telmisartan Telmisartan Telmisartan may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Daunorubicin is combined with Temozolomide.
Zaleplon Zaleplon The metabolism of Zaleplon can be increased when combined with Daunorubicin.
Anakinra Anakinra The risk or severity of adverse effects can be increased when Anakinra is combined with Daunorubicin.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Daunorubicin.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Daunorubicin.
Etanercept Injection Etanercept Injection The risk or severity of adverse effects can be increased when Etanercept is combined with Daunorubicin.
Tenofovir Tenofovir The metabolism of Tenofovir can be decreased when combined with Daunorubicin.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Daunorubicin.
Dutasteride Dutasteride The metabolism of Dutasteride can be increased when combined with Daunorubicin.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Daunorubicin.
Eplerenone Eplerenone The metabolism of Eplerenone can be increased when combined with Daunorubicin.
Olmesartan Olmesartan Olmesartan may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Zonisamide Zonisamide The metabolism of Zonisamide can be increased when combined with Daunorubicin.
Adalimumab Injection Adalimumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Daunorubicin.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Daunorubicin.
Ezetimibe Ezetimibe Daunorubicin may decrease the excretion rate of Ezetimibe which could result in a higher serum level.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Glatiramer.
Atazanavir Atazanavir Daunorubicin may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Rosuvastatin Rosuvastatin Daunorubicin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Daunorubicin.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Daunorubicin.
Aprepitant Aprepitant The metabolism of Aprepitant can be increased when combined with Daunorubicin.
Tadalafil Tadalafil The metabolism of Tadalafil can be increased when combined with Daunorubicin.
Progesterone Progesterone Progesterone may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Apomorphine Injection Apomorphine Injection The metabolism of Apomorphine can be increased when combined with Daunorubicin.
Darbepoetin Alfa Injection Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Daunorubicin.
Infliximab Injection Infliximab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Daunorubicin.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Daunorubicin.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Daunorubicin.
Tinidazole Tinidazole Daunorubicin may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan Bosentan may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Natalizumab.
Erlotinib Erlotinib The metabolism of Daunorubicin can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Daunorubicin.
Palifermin Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Daunorubicin.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Daunorubicin.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Daunorubicin.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Daunorubicin.
Tipranavir Tipranavir Tipranavir may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Ranolazine Ranolazine Ranolazine may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Abatacept Injection Abatacept Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Abatacept.
Imatinib Imatinib The risk or severity of adverse effects can be increased when Imatinib is combined with Daunorubicin.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Daunorubicin.
Gefitinib Gefitinib Gefitinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Paliperidone Paliperidone The metabolism of Paliperidone can be increased when combined with Daunorubicin.
Bortezomib Bortezomib The metabolism of Daunorubicin can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Daunorubicin.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Daunorubicin.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Daunorubicin.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Daunorubicin.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Daunorubicin.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Daunorubicin.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Daunorubicin.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Pemetrexed is combined with Daunorubicin.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Daunorubicin.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Daunorubicin is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Daunorubicin can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Daunorubicin.
Dronabinol Dronabinol Dronabinol may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Lapatinib Lapatinib The metabolism of Lapatinib can be increased when combined with Daunorubicin.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Daunorubicin.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Azacitidine.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Daunorubicin.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Daunorubicin.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Daunorubicin.
Bexarotene Bexarotene The risk or severity of adverse effects can be increased when Bexarotene is combined with Daunorubicin.
Budesonide Budesonide The risk or severity of adverse effects can be increased when Daunorubicin is combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Daunorubicin.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Decitabine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Mitoxantrone.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Daunorubicin is combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Bendamustine.
Certolizumab Injection Certolizumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Daunorubicin.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Daunorubicin.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Estramustine.
Praziquantel Praziquantel The metabolism of Praziquantel can be increased when combined with Daunorubicin.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Daunorubicin.
Rufinamide Rufinamide The metabolism of Rufinamide can be decreased when combined with Daunorubicin.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Daunorubicin.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Daunorubicin.
Eltrombopag Eltrombopag Eltrombopag may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Daunorubicin.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Daunorubicin.
Prasugrel Prasugrel The risk or severity of bleeding can be increased when Prasugrel is combined with Daunorubicin.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Daunorubicin.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Daunorubicin.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Daunorubicin.
Dronedarone Dronedarone The metabolism of Dronedarone can be decreased when combined with Daunorubicin.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Pralatrexate.
Saxagliptin Saxagliptin The metabolism of Saxagliptin can be increased when combined with Daunorubicin.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Daunorubicin.
Topotecan Topotecan The risk or severity of adverse effects can be increased when Daunorubicin is combined with Topotecan.
Golimumab Injection Golimumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Daunorubicin.
Pitavastatin Pitavastatin Daunorubicin may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Daunorubicin.
Levonorgestrel Levonorgestrel The metabolism of Levonorgestrel can be increased when combined with Daunorubicin.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Daunorubicin.
Dabigatran Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Daunorubicin.
Tocilizumab Injection Tocilizumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Tocilizumab.
Fingolimod Fingolimod Daunorubicin may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Daunorubicin.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Daunorubicin.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Daunorubicin.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Belimumab.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Daunorubicin.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Daunorubicin.
Linagliptin Linagliptin The metabolism of Linagliptin can be decreased when combined with Daunorubicin.
Rilpivirine Rilpivirine Rilpivirine may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Telaprevir Telaprevir Glecaprevir may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Daunorubicin can be decreased when combined with Cyclophosphamide.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be increased when combined with Daunorubicin.
Ticagrelor Ticagrelor The risk or severity of bleeding can be increased when Ticagrelor is combined with Daunorubicin.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Daunorubicin.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Daunorubicin.
Vandetanib Vandetanib The metabolism of Daunorubicin can be decreased when combined with Vandetanib.
Vemurafenib Vemurafenib The metabolism of Vemurafenib can be decreased when combined with Daunorubicin.
Vismodegib Vismodegib Vismodegib may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Belatacept.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be increased when combined with Daunorubicin.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Daunorubicin.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Daunorubicin.
Crizotinib Crizotinib The metabolism of Crizotinib can be decreased when combined with Daunorubicin.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Melphalan.
Cabergoline Cabergoline The metabolism of Daunorubicin can be decreased when combined with Cabergoline.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be increased when combined with Daunorubicin.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding can be increased when Fondaparinux is combined with Daunorubicin.
Pertuzumab Injection Pertuzumab Injection The risk or severity of cardiotoxicity can be increased when Daunorubicin is combined with Pertuzumab.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Carfilzomib.
Iloprost Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Daunorubicin.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be increased when combined with Daunorubicin.
Regorafenib Regorafenib The metabolism of Daunorubicin can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Bosutinib can be decreased when combined with Daunorubicin.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Corticotropin.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Daunorubicin is combined with Teriflunomide.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Daunorubicin.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Daunorubicin.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Daunorubicin is combined with Dimethyl fumarate.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Daunorubicin.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Daunorubicin.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Daunorubicin.
Apixaban Apixaban The metabolism of Apixaban can be increased when combined with Daunorubicin.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Daunorubicin.
Afatinib Afatinib Afatinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be increased when combined with Daunorubicin.
Perampanel Perampanel The metabolism of Perampanel can be increased when combined with Daunorubicin.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Daunorubicin.
Lomitapide Lomitapide The metabolism of Lomitapide can be decreased when combined with Daunorubicin.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Obinutuzumab.
Simeprevir Simeprevir Simeprevir may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Apremilast Apremilast The risk or severity of adverse effects can be increased when Daunorubicin is combined with Apremilast.
Ceritinib Ceritinib The metabolism of Ceritinib can be decreased when combined with Daunorubicin.
Siltuximab Injection Siltuximab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Siltuximab.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Belinostat.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Daunorubicin.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be increased when combined with Daunorubicin.
Vorapaxar Vorapaxar The metabolism of Daunorubicin can be decreased when combined with Vorapaxar.
Suvorexant Suvorexant The metabolism of Suvorexant can be decreased when combined with Daunorubicin.
Edoxaban Edoxaban The risk or severity of bleeding can be increased when Edoxaban is combined with Daunorubicin.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Daunorubicin.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Blinatumomab.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Daunorubicin.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Daunorubicin is combined with Pirfenidone.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Daunorubicin.
Secukinumab Injection Secukinumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Secukinumab.
Risperidone Injection Risperidone Injection The metabolism of Risperidone can be increased when combined with Daunorubicin.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Daunorubicin.
Lenvatinib Lenvatinib Lenvatinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Daunorubicin.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Daunorubicin.
Deoxycholic Acid Injection Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Daunorubicin which could result in a lower serum level and potentially a reduction in efficacy.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Daunorubicin.
Rolapitant Rolapitant Rolapitant may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Prednisolone Prednisolone The risk or severity of adverse effects can be increased when Daunorubicin is combined with Prednisolone.
Daclatasvir Daclatasvir Daclatasvir may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Ziprasidone Injection Ziprasidone Injection The metabolism of Ziprasidone can be decreased when combined with Daunorubicin.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Daunorubicin.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Daunorubicin.
Osimertinib Osimertinib The metabolism of Osimertinib can be decreased when combined with Daunorubicin.
Alectinib Alectinib The metabolism of Daunorubicin can be decreased when combined with Alectinib.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Daunorubicin.
Dexamethasone Injection Dexamethasone Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Dexamethasone.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Daunorubicin.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Ixekizumab.
Venetoclax Venetoclax The metabolism of Venetoclax can be decreased when combined with Daunorubicin.
Cobicistat Cobicistat Cobicistat may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Rucaparib Rucaparib Rucaparib may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Ribociclib Ribociclib The metabolism of Ribociclib can be decreased when combined with Daunorubicin.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Brodalumab.
Brigatinib Brigatinib The metabolism of Brigatinib can be decreased when combined with Daunorubicin.
Deutetrabenazine Deutetrabenazine The metabolism of Deutetrabenazine can be increased when combined with Daunorubicin.
Valbenazine Valbenazine The metabolism of Valbenazine can be increased when combined with Daunorubicin.
Deflazacort Deflazacort The risk or severity of adverse effects can be increased when Daunorubicin is combined with Deflazacort.
Safinamide Safinamide Safinamide may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Ocrelizumab Injection Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Daunorubicin.
Sarilumab Injection Sarilumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Midostaurin can be decreased when combined with Daunorubicin.
Neratinib Neratinib The metabolism of Neratinib can be decreased when combined with Daunorubicin.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Guselkumab.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Daunorubicin.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Daunorubicin.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Daunorubicin.
Abemaciclib Abemaciclib The metabolism of Daunorubicin can be decreased when combined with Abemaciclib.
Betrixaban Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Daunorubicin.
Acalabrutinib Acalabrutinib The metabolism of Acalabrutinib can be decreased when combined with Daunorubicin.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Daunorubicin.
Letermovir Letermovir Letermovir may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Buprenorphine Injection Buprenorphine Injection Buprenorphine may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Apalutamide Apalutamide Apalutamide may increase the excretion rate of Daunorubicin which could result in a lower serum level and potentially a reduction in efficacy.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Penicillamine.
Fostamatinib Fostamatinib Fostamatinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Avatrombopag Avatrombopag Avatrombopag may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Daunorubicin.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Daunorubicin.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Daunorubicin.
Doravirine Doravirine The metabolism of Doravirine can be increased when combined with Daunorubicin.
Cannabidiol Cannabidiol Cannabidiol may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Dacomitinib Dacomitinib The metabolism of Daunorubicin can be decreased when combined with Dacomitinib.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Daunorubicin.
Gilteritinib Gilteritinib Gilteritinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Glasdegib Glasdegib Glasdegib may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be increased when combined with Daunorubicin.
Methoxy Polyethylene Glycol-Epoetin Beta Injection Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Daunorubicin.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Daunorubicin.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Daunorubicin.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Daunorubicin.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Daunorubicin.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Daunorubicin.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Risankizumab.
Alpelisib Alpelisib The metabolism of Alpelisib can be decreased when combined with Daunorubicin.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Daunorubicin.
Darolutamide Darolutamide Darolutamide may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Entrectinib Entrectinib The metabolism of Entrectinib can be decreased when combined with Daunorubicin.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Daunorubicin.
Istradefylline Istradefylline The metabolism of Istradefylline can be increased when combined with Daunorubicin.
Fedratinib Fedratinib Fedratinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Lefamulin Lefamulin The metabolism of Lefamulin can be decreased when combined with Daunorubicin.
Phenytoin Injection Phenytoin Injection The metabolism of Phenytoin can be increased when combined with Daunorubicin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Daunorubicin.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Daunorubicin.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Daunorubicin.
Lasmiditan Lasmiditan The serum concentration of Daunorubicin can be increased when it is combined with Lasmiditan.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Daunorubicin.
Cenobamate Cenobamate The metabolism of Cenobamate can be increased when combined with Daunorubicin.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Daunorubicin is combined with Ozanimod.
Selumetinib Selumetinib The metabolism of Selumetinib can be increased when combined with Daunorubicin.
Rimegepant Rimegepant The metabolism of Rimegepant can be increased when combined with Daunorubicin.
Ripretinib Ripretinib Ripretinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Selpercatinib Selpercatinib The serum concentration of Selpercatinib can be decreased when it is combined with Daunorubicin.
Capmatinib Capmatinib The serum concentration of Capmatinib can be decreased when it is combined with Daunorubicin.
Lemborexant Lemborexant The serum concentration of Lemborexant can be decreased when it is combined with Daunorubicin.
Fostemsavir Fostemsavir Fostemsavir may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Daunorubicin may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib Pralsetinib Pralsetinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Margetuximab-cmkb Injection Margetuximab-cmkb Injection The risk or severity of cardiotoxicity can be increased when Margetuximab is combined with Daunorubicin.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be decreased when combined with Daunorubicin.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Daunorubicin.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Daunorubicin.
Naproxen Naproxen Daunorubicin may decrease the excretion rate of Naproxen which could result in a higher serum level.
Trazodone Trazodone The metabolism of Trazodone can be increased when combined with Daunorubicin.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Daunorubicin is combined with Hydroxyurea.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Daunorubicin.
Phenobarbital Phenobarbital Phenobarbital may increase the excretion rate of Daunorubicin which could result in a lower serum level and potentially a reduction in efficacy.
Methotrexate Injection Methotrexate Injection The metabolism of Daunorubicin can be decreased when combined with Methotrexate.
Chlorpromazine Chlorpromazine Daunorubicin may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.
Diazepam Diazepam The metabolism of Diazepam can be increased when combined with Daunorubicin.
Lorazepam Lorazepam The metabolism of Lorazepam can be decreased when combined with Daunorubicin.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Daunorubicin.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Procarbazine.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Daunorubicin.
Prochlorperazine Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Daunorubicin.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Daunorubicin.
Dapsone Dapsone The metabolism of Dapsone can be increased when combined with Daunorubicin.
Oxycodone Oxycodone The metabolism of Oxycodone can be increased when combined with Daunorubicin.
Methadone Methadone The metabolism of Methadone can be increased when combined with Daunorubicin.
Oxybutynin Oxybutynin The metabolism of Oxybutynin can be increased when combined with Daunorubicin.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Azathioprine.
Phentermine Phentermine The metabolism of Phentermine can be decreased when combined with Daunorubicin.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Sulfasalazine.
Hydrocortisone Hydrocortisone The metabolism of Hydrocortisone can be increased when combined with Daunorubicin.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Lomustine.
Doxorubicin Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Daunorubicin.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Daunorubicin is combined with Dactinomycin.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Daunorubicin.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Daunorubicin.
Cimetidine Cimetidine Cimetidine may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Warfarin Warfarin The serum concentration of Warfarin can be increased when it is combined with Daunorubicin.
Nitrofurantoin Nitrofurantoin Daunorubicin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Digoxin Digoxin Digoxin may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Chloroquine Chloroquine The metabolism of Chloroquine can be increased when combined with Daunorubicin.
Quinine Quinine The metabolism of Quinine can be increased when combined with Daunorubicin.
Sulfinpyrazone Sulfinpyrazone Sulfinpyrazone may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Chlorothiazide Chlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Daunorubicin.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be increased when combined with Daunorubicin.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be increased when combined with Daunorubicin.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Daunorubicin.
Rifampin Rifampin Rifampicin may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Tamoxifen Tamoxifen The metabolism of Daunorubicin can be decreased when combined with Tamoxifen.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Daunorubicin.
Methimazole Methimazole The risk or severity of adverse effects can be increased when Daunorubicin is combined with Methimazole.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Daunorubicin.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be increased when combined with Daunorubicin.
Chlorpheniramine Chlorpheniramine The metabolism of Chlorpheniramine can be increased when combined with Daunorubicin.
Methyclothiazide Methyclothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Daunorubicin.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Daunorubicin.
Disulfiram Disulfiram Daunorubicin may decrease the excretion rate of Disulfiram which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Propranolol can be increased when combined with Daunorubicin.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Daunorubicin.
Spironolactone Spironolactone Spironolactone may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Mercaptopurine.
Allopurinol Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Daunorubicin.
Fluorouracil Injection Fluorouracil Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Daunorubicin.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Daunorubicin.
Cefaclor Cefaclor Daunorubicin may decrease the excretion rate of Cefaclor which could result in a higher serum level.
Cephalexin Cephalexin The metabolism of Cephalexin can be decreased when combined with Daunorubicin.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Dacarbazine.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Daunorubicin.
Ketoconazole Ketoconazole Ketoconazole may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Daunorubicin.
Vincristine Injection Vincristine Injection The metabolism of Vincristine can be decreased when combined with Daunorubicin.
Dipyridamole Dipyridamole Daunorubicin may decrease the excretion rate of Dipyridamole which could result in a higher serum level.
Vinblastine Vinblastine The metabolism of Daunorubicin can be decreased when combined with Vinblastine.
Metoprolol Metoprolol The metabolism of Metoprolol can be decreased when combined with Daunorubicin.
Hydroxyzine Hydroxyzine The metabolism of Hydroxyzine can be increased when combined with Daunorubicin.
Aspirin Aspirin The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Daunorubicin.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Daunorubicin.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Daunorubicin.
Triazolam Triazolam The metabolism of Triazolam can be increased when combined with Daunorubicin.
Diltiazem Diltiazem The metabolism of Diltiazem can be increased when combined with Daunorubicin.
Nifedipine Nifedipine Nifedipine may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Verapamil Verapamil The metabolism of Verapamil can be increased when combined with Daunorubicin.
Atenolol Atenolol Atenolol may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Daunorubicin.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Daunorubicin.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Daunorubicin.
Glyburide Glyburide Glyburide may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Glipizide Glipizide Daunorubicin may decrease the excretion rate of Glipizide which could result in a higher serum level.
Pentoxifylline Pentoxifylline The risk or severity of bleeding can be increased when Pentoxifylline is combined with Daunorubicin.
Pentamidine Injection Pentamidine Injection The metabolism of Pentamidine can be increased when combined with Daunorubicin.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Daunorubicin.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Daunorubicin.
Buspirone Buspirone The metabolism of Buspirone can be increased when combined with Daunorubicin.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Daunorubicin.
Diclofenac Diclofenac Diclofenac may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Daunorubicin.
Clozapine Clozapine The risk or severity of neutropenia can be increased when Daunorubicin is combined with Clozapine.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Daunorubicin is combined with Idarubicin.
Ofloxacin Ofloxacin Daunorubicin may decrease the excretion rate of Ofloxacin which could result in a higher serum level.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Fludarabine.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Daunorubicin.
Clarithromycin Clarithromycin Daunorubicin may decrease the excretion rate of Clarithromycin which could result in a higher serum level.
Felodipine Felodipine Daunorubicin may decrease the excretion rate of Felodipine which could result in a higher serum level.
Pravastatin Pravastatin Pravastatin may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Simvastatin Simvastatin Daunorubicin may decrease the excretion rate of Simvastatin which could result in a higher serum level.
Epoetin Alfa, Injection Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Daunorubicin.
Teniposide Injection Teniposide Injection The metabolism of Daunorubicin can be decreased when combined with Teniposide.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Daunorubicin.
Isradipine Isradipine Isradipine may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Omeprazole Omeprazole Omeprazole may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Cisapride Cisapride The metabolism of Cisapride can be decreased when combined with Daunorubicin.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be increased when combined with Daunorubicin.
Venlafaxine Venlafaxine Venlafaxine may increase the excretion rate of Daunorubicin which could result in a lower serum level and potentially a reduction in efficacy.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Daunorubicin.
Fluvoxamine Fluvoxamine Fluvoxamine may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Nefazodone Nefazodone Daunorubicin may decrease the excretion rate of Nefazodone which could result in a higher serum level.
Losartan Losartan Losartan may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Daunorubicin.
Vinorelbine Injection Vinorelbine Injection The metabolism of Daunorubicin can be decreased when combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Daunorubicin is combined with Carboplatin.
Lansoprazole Lansoprazole Lansoprazole may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Daunorubicin.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Daunorubicin.
Nicardipine Nicardipine Nicardipine may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Ticlopidine Ticlopidine The metabolism of Daunorubicin can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir Saquinavir may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Daunorubicin.
Nisoldipine Nisoldipine The metabolism of Nisoldipine can be increased when combined with Daunorubicin.
Glimepiride Glimepiride Glimepiride may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Anastrozole Anastrozole The risk or severity of cardiotoxicity can be increased when Daunorubicin is combined with Anastrozole.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Daunorubicin.
Indinavir Indinavir Daunorubicin may decrease the excretion rate of Indinavir which could result in a higher serum level.
Ritonavir Ritonavir Ritonavir may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Daunorubicin.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Daunorubicin.
Zafirlukast Zafirlukast The metabolism of Zafirlukast can be decreased when combined with Daunorubicin.
Nelfinavir Nelfinavir Nelfinavir may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Azithromycin Azithromycin The metabolism of Azithromycin can be decreased when combined with Daunorubicin.
Loratadine Loratadine Loratadine may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Flutamide Flutamide The metabolism of Flutamide can be increased when combined with Daunorubicin.
Bicalutamide Bicalutamide The metabolism of Bicalutamide can be decreased when combined with Daunorubicin.
Finasteride Finasteride The metabolism of Finasteride can be increased when combined with Daunorubicin.
Quetiapine Quetiapine The metabolism of Quetiapine can be increased when combined with Daunorubicin.
Capecitabine Capecitabine The risk or severity of adverse effects can be increased when Daunorubicin is combined with Capecitabine.
Efavirenz Efavirenz Efavirenz may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Sildenafil Sildenafil The metabolism of Sildenafil can be increased when combined with Daunorubicin.
Trastuzumab Injection Trastuzumab Injection The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Daunorubicin.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Rosiglitazone Rosiglitazone Rosiglitazone may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Daunorubicin is combined with Thalidomide.
Nateglinide Nateglinide The metabolism of Nateglinide can be increased when combined with Daunorubicin.
Rabeprazole Rabeprazole Rabeprazole may decrease the excretion rate of Daunorubicin which could result in a higher serum level.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists